Rnc Capital Management LLC Bristol Myers Squibb CO Transaction History

Rnc Capital Management LLC

$1.84 Billion
Q3 2024

A detailed history of Rnc Capital Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Rnc Capital Management LLC holds 739,132 shares of BMY stock, worth $42.7 Million. This represents 2.08% of its overall portfolio holdings.

Number of Shares

739,132

Previous 739,132 -0.0%

Holding current value

$42.7 Million

Previous $30.7 Million 24.61%

% of portfolio

2.08%

Previous 1.77%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $832,370 - $1.1 Million	20,680 Added 2.88%	739,132 $30.7 Million
Q1 2024 Aug 07, 2024	BUY	$47.98 - $54.4 $2.84 Million - $3.22 Million	59,250 Added 8.99%	718,452 $39 Million
Q4 2023 Jan 17, 2024	SELL	$48.48 - $57.85 $7.64 Million - $9.11 Million	-157,502 Reduced 19.29%	659,202 $33.8 Million
Q3 2023 Dec 27, 2023	SELL	$57.89 - $64.73 $6.76 Million - $7.55 Million	-116,710 Reduced 12.5%	816,704 $47.4 Million
Q2 2023 Jul 20, 2023	SELL	$63.71 - $70.74 $1.65 Million - $1.84 Million	-25,960 Reduced 2.71%	933,414 $59.7 Million
Q1 2023 Apr 21, 2023	SELL	$65.71 - $74.53 $602,757 - $683,663	-9,173 Reduced 0.95%	959,374 $66.5 Million
Q4 2022 Jan 10, 2023	BUY	$68.48 - $81.09 $796,696 - $943,401	11,634 Added 1.22%	968,547 $69.7 Million
Q3 2022 Oct 18, 2022	SELL	$0.13 - $76.84 $1,066 - $630,625	-8,207 Reduced 0.85%	956,913 $68 Million
Q2 2022 Jul 22, 2022	BUY	$72.62 - $79.98 $1.39 Million - $1.53 Million	19,129 Added 2.02%	965,120 $74.3 Million
Q1 2022 Jul 22, 2022	SELL	$61.48 - $73.72 $6.13 Million - $7.35 Million	-99,760 Reduced 9.54%	945,991 $69.1 Million
Q4 2021 Feb 04, 2022	BUY	$53.63 - $62.52 $5.91 Million - $6.89 Million	110,252 Added 11.79%	1,045,751 $65.2 Million
Q3 2021 Nov 02, 2021	BUY	$59.17 - $69.31 $186,622 - $218,603	3,154 Added 0.34%	935,499 $55.4 Million
Q2 2021 Jul 20, 2021	BUY	$61.91 - $67.42 $10.2 Million - $11.1 Million	165,001 Added 21.5%	932,345 $62.3 Million
Q1 2021 Apr 26, 2021	BUY	$59.34 - $66.74 $1.13 Million - $1.27 Million	19,045 Added 2.55%	767,344 $48.4 Million
Q4 2020 Jan 13, 2021	BUY	$57.74 - $65.43 $375,136 - $425,098	6,497 Added 0.88%	748,299 $46.4 Million
Q3 2020 Dec 03, 2020	SELL	$57.43 - $63.64 $756,984 - $838,838	-13,181 Reduced 1.75%	741,802 $44.7 Million
Q2 2020 Jul 23, 2020	SELL	$54.82 - $64.09 $1.4 Million - $1.63 Million	-25,483 Reduced 3.27%	754,983 $44.4 Million
Q1 2020 Apr 22, 2020	SELL	$46.4 - $67.43 $562,228 - $817,049	-12,117 Reduced 1.53%	780,466 $43.5 Million
Q4 2019 Mar 09, 2020	BUY	$49.21 - $64.19 $292,012 - $380,903	5,934 Added 0.75%	792,583 $50.9 Million
Q3 2019 Jul 22, 2020	SELL	$42.77 - $50.71 $1.84 Million - $2.19 Million	-43,103 Reduced 5.19%	786,649 $39.9 Million
Q2 2019 Jul 25, 2019	SELL	$44.62 - $49.34 $1.32 Million - $1.46 Million	-29,540 Reduced 3.44%	829,752 $37.6 Million
Q1 2019 Apr 18, 2019	BUY	$45.12 - $53.8 $1.83 Million - $2.18 Million	40,474 Added 4.94%	859,292 $41 Million
Q4 2018 Jan 15, 2019	SELL	$48.76 - $63.23 $2.57 Million - $3.33 Million	-52,704 Reduced 6.05%	818,818 $42.6 Million
Q3 2018 Oct 25, 2018	SELL	$55.19 - $62.25 $62,088 - $70,031	-1,125 Reduced 0.13%	871,522 $54.1 Million
Q2 2018 Jul 20, 2018	BUY	$50.53 - $62.98 $539,104 - $671,933	10,669 Added 1.24%	872,647 $48.3 Million
Q1 2018 Apr 11, 2018	BUY	$59.92 - $68.98 $648,454 - $746,501	10,822 Added 1.27%	861,978 $54.5 Million
Q4 2017 Jan 17, 2018	BUY	$59.94 - $65.35 $496,063 - $540,836	8,276 Added 0.98%	851,156 $52.2 Million
Q3 2017 Oct 16, 2017	BUY	$55.23 - $63.74 $1.07 Million - $1.23 Million	19,314 Added 2.35%	842,880 $53.7 Million
Q2 2017 Aug 22, 2017	BUY	N/A	823,566	823,566 $45.9 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rnc Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rnc Capital Management LLC with notifications on news.

Account

Rnc Capital Management LLC Bristol Myers Squibb CO Transaction History